GeoVax Labs Inc. (GOVX.OB) Announces “Excellent” Results in AIDS Treatment
According to the most recent statistics from the Centers for Disease Control and Prevention, approximately 448,871 people were living with AIDS in the United States in 2006, 3,775 of which were children under the age of 13. That same year, 565,927 persons died from AIDS, 5,369 of which were under age 13. GeoVax Labs Inc. (OTCBB: GOVX) is a biopharmaceutical company focused on the prevention and treatment of infectious diseases. The company today announced its updated progress of its phase 2 preventative human clinical trial testing; the company said it will move forward with therapeutic human trials with its AIDS…